Anti-drug Antibodies Formation During Tapering and Stopping of Methotrexate in Rheumatoid Arthritis Patients with Longstanding Use of Adalimumab

被引：0
|
作者：
Layegh, Zohra [1 ]
de Jong, Pascal [1 ]
Atiqi, Sadaf [2 ]
Loeff, Floris [3 ]
Dijk, Lisanne [3 ]
Vaz, Gaelle [3 ]
Dolhain, Radboud J. E. M. [4 ]
Rispens, Theo [3 ]
Wolbink, Gertjan [5 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
[2] Dept Rheumatol, Amsterdam Rheumatol & Immunol Ctr, Locat Reade, Dr Jan Breemenstr 2, NL-1056 AB Amsterdam, Netherlands
[3] Sanquin Diagnost Serv, Biol Lab, Amsterdam, Netherlands
[4] Erasmus MC, Rheumatol, Rotterdam, Netherlands
[5] Reade, Amsterdam, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1077
引用
收藏
页码：2121 / 2122
页数：2
相关论文
共 50 条
  • [1] Presence of anti-nuclear antibodies is a risk factor for the appearance of anti-drug antibodies during infliximab or adalimumab therapy in patients with rheumatoid arthritis
    Mori, Ayano
    Saito, Toshiharu
    Takahashi, Miho
    Shibata, Miho
    Tsuji, Goh
    Hatachi, Saori
    Takahashi, Soshi
    Kumagai, Shunichi
    PLOS ONE, 2020, 15 (12):
  • [2] Systematic comparison of drug-tolerant assays for anti-drug antibodies in a cohort of adalimumab-treated rheumatoid arthritis patients
    Bloem, Karien
    van Leeuwen, Astrid
    Verbeek, Gerrit
    Nurmohamed, Michael T.
    Wolbink, Gerrit Jan
    van der Kleij, Desiree
    Rispens, Theo
    JOURNAL OF IMMUNOLOGICAL METHODS, 2015, 418 : 29 - 38
  • [3] The addition of adalimumab to methotrexate reduces rheumatoid arthritis activity in patients with longstanding disease
    Matucci-Cerinic, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (01) : 34 - 35
  • [4] Incidence of Anti-Drug Antibodies in Rheumatoid Arthritis Patients Treated with Adalimumab, Etanercept, or Infliximab in a Real-World Setting
    Moots, R. J.
    Xavier, Ricardo
    Mok, Chi Chiu
    Rahman, Mahboob U.
    Tsai, Wen-Chan
    Al Maini, Mustafa
    Pavelka, Karel
    Mahgoub, Ehab
    Kotak, Sameer
    Korth-Bradley, Joan
    Pedersen, Ronald
    Mele, Linda
    Shen, Qi
    Vlahos, Bonnie
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [5] Relationship Between Adalimumab Concentrations, Plasma Cytokines, Anti-drug Antibodies and Disease Activity in Rheumatoid Arthritis
    Stamp, Lisa
    Keating, Paula
    Frampton, Christopher
    Barclay, Murray
    Fanning, Niamh
    Millier, Melanie
    Hessian, Paul
    O'Donnell, John
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [6] Gammaglobulins, autoantibodies, therapeutic antibodies and anti-drug antibodies in rheumatoid arthritis
    Gottenberg, J. -E.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 178 : 115 - 117
  • [7] Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis
    Quistrebert, Jocelyn
    Hassler, Signe
    Bachelet, Delphine
    Mbogning, Cyprien
    Musters, Anne
    Tak, Paul Peter
    Wijbrandts, Carla Ann
    Herenius, Marieke
    Bergstra, Sytske Anne
    Akdemir, Gulsah
    Johannesson, Martina
    Combe, Bernard
    Fautrel, Bruno
    Chollet-Martin, Sylvie
    Gleizes, Aude
    Donnellan, Naoimh
    Deisenhammer, Florian
    Davidson, Julie
    Hincelin-Mery, Agnes
    Donnes, Pierre
    Fogdell-Hahn, Anna
    De Vries, Niek
    Huizinga, Tom
    Abugessaisa, Imad
    Saevarsdottir, Saedis
    Hacein-Bey-Abina, Salima
    Pallardy, Marc
    Broet, Philippe
    Mariette, Xavier
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 48 (06) : 967 - 975
  • [8] Early Anti-Drug Antibodies Predict Adalimumab Response in Juvenile Idiopathic Arthritis
    Huang, Bo-Han
    Hsu, Jr-Lin
    Huang, Hsin-Yi
    Huang, Jing-Long
    Yeh, Kuo-Wei
    Chen, Li-Chen
    Lee, Wen-, I
    Yao, Tsung-Chieh
    Ou, Liang-Shiou
    Lin, Syh-Jae
    Su, Kuan-Wen
    Wu, Chao-Yi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)
  • [9] Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levels
    Jani, Meghna
    Isaacs, John D.
    Morgan, Ann W.
    Wilson, Anthony G.
    Plant, Darren
    Hyrich, Kimme L.
    Chinoy, Hector
    Barton, Anne
    RHEUMATOLOGY, 2016, 55 (11) : 2050 - 2055
  • [10] Concentrations of infliximab and anti-drug antibodies in relation to clinical response in patients with rheumatoid arthritis
    Siljehult, F.
    Arlestig, L.
    Eriksson, C.
    Rantapaa-Dahlqvist, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (05) : 345 - 350
12345